TY - JOUR
T1 - Understanding, Recognizing, and Managing Functional Speech Disorders
T2 - Current Thinking Illustrated With a Case Series
AU - Utianski, Rene L.
AU - Duffy, Joseph R.
N1 - Funding Information:
The authors extend gratitude to the patients who con-sented to share their journeys and to the neurologists with whom we partnered with to facilitate patients’ understanding of FSDs. The first author extends appreciation to the writing group, “The Write Stuff,” for providing a regularly scheduled, dedicated, and encouraging writing environ-ment. Finally, the first author submitted one of these cases (unpublished) as a part of the Academy of Neurologic Communication Disorders and Sciences Board Certifica-tion process.
Publisher Copyright:
© 2022 American Speech-Language-Hearing Association.
PY - 2022/5
Y1 - 2022/5
N2 - Purpose: Functional speech disorders (FSDs), a subtype of functional neurological disorders, are distinguishable from neurogenic motor speech disorders based on their clinical features, clinical course, and response to treatment. However, their differential diagnosis and management can be challenging. FSDs are not well understood, but growing evidence suggests a biopsychosocial basis distinct from structural lesions that cause neurogenic motor speech disorders. Method and Results: Following an overview of FSDs, four patients are described to illustrate the range of clinical manifestations, biopsychosocial con-texts, and responses to treatment of FSDs. The path to differential diagnosis is discussed, with particular attention to positive features that led to the FSD diag-nosis. Approaches to education, counseling, and management are discussed. Conclusions: This case series demonstrates that FSDs can present with a vari-ety of manifestations including dysfluencies, articulation errors, dysphonia, rate and prosodic abnormalities, and combinations of disruptions in speech subsys-tems. FSDs may present in the context of known recent or remote physical or psychosocial trauma or, as in many cases, in the absence of an identifiable trig-gering event. FSDs are recognizable by positive clinical features and should not be considered a diagnosis of exclusion. With appropriate identification, counsel-ing, and treatment, FSDs may resolve, sometimes rapidly; in some cases, treatment may be prolonged or ineffective.
AB - Purpose: Functional speech disorders (FSDs), a subtype of functional neurological disorders, are distinguishable from neurogenic motor speech disorders based on their clinical features, clinical course, and response to treatment. However, their differential diagnosis and management can be challenging. FSDs are not well understood, but growing evidence suggests a biopsychosocial basis distinct from structural lesions that cause neurogenic motor speech disorders. Method and Results: Following an overview of FSDs, four patients are described to illustrate the range of clinical manifestations, biopsychosocial con-texts, and responses to treatment of FSDs. The path to differential diagnosis is discussed, with particular attention to positive features that led to the FSD diag-nosis. Approaches to education, counseling, and management are discussed. Conclusions: This case series demonstrates that FSDs can present with a vari-ety of manifestations including dysfluencies, articulation errors, dysphonia, rate and prosodic abnormalities, and combinations of disruptions in speech subsys-tems. FSDs may present in the context of known recent or remote physical or psychosocial trauma or, as in many cases, in the absence of an identifiable trig-gering event. FSDs are recognizable by positive clinical features and should not be considered a diagnosis of exclusion. With appropriate identification, counsel-ing, and treatment, FSDs may resolve, sometimes rapidly; in some cases, treatment may be prolonged or ineffective.
UR - http://www.scopus.com/inward/record.url?scp=85130001688&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85130001688&partnerID=8YFLogxK
U2 - 10.1044/2021_AJSLP-21-00366
DO - 10.1044/2021_AJSLP-21-00366
M3 - Article
C2 - 35290099
AN - SCOPUS:85130001688
SN - 1058-0360
VL - 31
SP - 1205
EP - 1220
JO - American Journal of Speech-Language Pathology
JF - American Journal of Speech-Language Pathology
IS - 3
ER -